Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

PROVEN TO PERFORM

Explore clinical data about the InterStimTM system and patient outcomes.

Alert Indications, Safety, and Warnings

BACKED BY SCIENCE, DRIVEN TO INNOVATION

Twenty years ago, Medtronic introduced sacral neuromodulation (SNM) and transformed how clinicians treat bladder and bowel control problems. Today, our therapies continue to demonstrate effective and lasting results in multiple studies.1,2

Female Pelvic Health Physician

EVIDENCE FOR BLADDER CONTROL

See evidence that demonstrates the efficacy of the InterStimTM system for reducing the symptoms of overactive bladder and non-obstructive urinary retention.1,3

SEE BLADDER SUMMARY

EVIDENCE FOR BOWEL CONTROL

View key data that prove the InterStimTM system can provide long-term relief of the symptoms of chronic fecal incontinence.2

SEE BOWEL SUMMARY

PURSUE ONLINE EDUCATION

Take convenient courses specifically designed for clinicians treating patients with OAB, non-obstructive urinary retention, and chronic fecal incontinence.

SEE COURSES
Doctor speaking with female pelvic health patient

EXPECT EXTENSIVE REPORT

Get your questions answered and your concerns resolved.

EXPLORE RESOURCES

REAL PEOPLE, REAL RELIEF

Life-changing relief with Medtronic control therapies.

READ THE STORIES
Female pelvic health patient is able to now enjoy time outdoors with her horse.
1

Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. The Journal of Urology 2018;Volume 199(1), 229–236.

2

Hull T, Giese C, Wexner SD, Mellgren A, Devroede G, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56:234–245.

3

Medtronic InterStimTM Therapy Clinical Data Summary (2018).